OBJECTIVE: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer. OUTCOMES: Outcomes of interest included prevention of morbidity and ...

Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up. Seventy-eight patients undergoing induction therapy for acute leukemia were randomized to receive ...

August 23, 2012 — German researchers suggest that therapeutic platelet transfusion could become a new standard of care in patients with hematological malignancies who receive autologous stem cell ...

A preliminary study published in this week's issue of THE LANCET suggests a possible explanation for the biological process responsible for inducing fever and related symptoms after the transfusion of ...

Myelodysplastic syndromes (MDS) can damage bone marrow, lowering red blood cells and platelets. Transfusions replace missing cells to manage anemia or thrombocytopenia. Up to 9 in 10 people with MDS ...

Background: Transfusion-dependent bone marrow transplant recipients are routinely transfused with ABO group and RhD-compatible blood components. However, because of the scarcity of RhD-negative blood ...

Four people in three states developed sepsis after receiving bacteria-contaminated platelet transfusions between May and October last year, according to a US government report released Thursday. One ...

Please provide your email address to receive an email when new articles are posted on . Patients with severe thrombocytopenia who did not receive prophylactic transfusion before catheter placement had ...

When the polar vortex froze out residents in much the United States in January, it also sent chills through the U.S. blood system, especially for people who needed platelets. “If you are safely able ...